✦ LIBER ✦
A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy
✍ Scribed by Mark Clemons; George Dranitsaris; Wei Ooi; David E. C. Cole
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 346 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.